Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.5000
+0.1400 (38.89%)
Sep 24, 2026, 4:00 PM EST
Avenue Therapeutics Market Cap
Avenue Therapeutics has a market cap or net worth of $1.65 million as of September 25, 2026. Its market cap has decreased by -35.31% in one year.
Market Cap
1.65M
Enterprise Value
-294.52K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.50
ChartMarket Cap Chart
Since June 27, 2017, Avenue Therapeutics's market cap has decreased from 27.57M to 1.65M, a decrease of -94.02%. That is a compound annual growth rate of -26.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 1.65M | -23.92% |
| Dec 31, 2025 | 2.17M | -47.28% |
| Dec 31, 2024 | 4.11M | 92.60% |
| Dec 29, 2023 | 2.13M | -61.53% |
| Dec 30, 2022 | 5.54M | -70.79% |
| Dec 31, 2021 | 18.98M | -80.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaccinex | 2.41M |
| Abpro Holdings | 2.33M |
| Bioxytran | 2.31M |
| VitaSpring Biomedical | 2.30M |
| Enzolytics | 1.93M |
| AccuStem Sciences | 1.93M |
| NKGen Biotech | 1.57M |
| Protagenic Therapeutics | 1.48M |